Orchid Pharma Limited has informed the Exchange about Schedule of meet for Quarter IV and Financial Year ended on May 26, 2025
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has informed the exchanges about an Analysts/Investors Earnings Call scheduled for Monday, May 26, 2025 at 4:30 PM IST. The call, hosted by Systematix Institutional Equities, will discuss the company's financial performance and results for the fourth quarter and full financial year ended March 31, 2025. Management will be represented by Managing Director Manish Dhanuka, Whole Time Director Mridul Dhanuka, and CFO Sunil Kumar Gupta. Dial-in numbers have been provided for participants across India, USA, UK, Singapore, and Hong Kong. The filing is a routine procedural disclosure under SEBI Listing Regulations, and the schedule is subject to change due to unforeseen circumstances.
This is a routine advance intimation of the upcoming earnings call and carries no direct material impact on the stock. Investors should watch the call for commentary on FY25 results, margin trends, and management outlook, which could influence near-term sentiment.